Liječnički vjesnik, Vol. 139 No. 1-2, 2017.
Stručni rad
CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part V: melanoma, sarcomas, central nerve system tumors, lung cancer
Davorin Herceg
Marko Jakopović
Natalija Dedić Plavetić
Miroslav Samaržija
Branka Čučević
Davor Mijatović
Igor Nikolić
Dragan Trivanović
Robert Šeparović
Damir Vrbanec
Sažetak
Treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized
oncological centers. By the end of a specifi c oncological treatment further follow-up is being managed mostly by the
oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely
defi ned. Nowadays, most of the existing follow-up guidelines are not being based on prospective studies, yet on the expert’s opinion of a precise oncological center or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with
these recommendations is to standardize and rationalize the diagnostic procedures’ algorithm in follow–up of oncological
patients after primary treatment, in patients with melanoma, sarcomas, central nerve system tumors and lung cancer
Ključne riječi
Melanoma – diagnosis, pathology, therapy; Skin neoplasms – diagnosis, pathology, therapy; Sarcoma – diagnosis, pathology, therapy; Soft tissue neoplasms – diagnosis, pathology, therapy; Gastrointestinal stromal tumors – diagnosis, pathology, therapy; Bone neoplasms – diagnosis, pathology, therapy; Central nervous system neoplasms – diagnosis, pathology, therapy; Lung neoplasms – diagnosis, pathology, therapy; Carcinoma, non-small-cell lung – diagnosis, pathology, therapy; Practice guidelines as topic – standards; Medical oncology – standards; Croatia; Follow-up studies
Hrčak ID:
178440
URI
Datum izdavanja:
23.3.2017.
Posjeta: 4.762 *